Exchange: NASDAQ·Updated 07:32 PM EST

About FRNM

About

Freenome, Inc. operates as an early detection company, which engages in the development of blood-based screening tests to detect cancer. Its proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers. The company was founded by Riley Ennis in 2014 and is headquartered in Brisbane, CA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
3

Frequently Asked Questions

Advertisement|Remove ads.